201 related articles for article (PubMed ID: 15668141)
1. BMP gene delivery for alveolar bone engineering at dental implant defects.
Dunn CA; Jin Q; Taba M; Franceschi RT; Bruce Rutherford R; Giannobile WV
Mol Ther; 2005 Feb; 11(2):294-9. PubMed ID: 15668141
[TBL] [Abstract][Full Text] [Related]
2. In vivo molecular imaging of adenoviral versus lentiviral gene therapy in two bone formation models.
Feeley BT; Conduah AH; Sugiyama O; Krenek L; Chen IS; Lieberman JR
J Orthop Res; 2006 Aug; 24(8):1709-21. PubMed ID: 16788987
[TBL] [Abstract][Full Text] [Related]
3. Combination of scaffold and adenovirus vectors expressing bone morphogenetic protein-7 for alveolar bone regeneration at dental implant defects.
Zhang Y; Song J; Shi B; Wang Y; Chen X; Huang C; Yang X; Xu D; Cheng X; Chen X
Biomaterials; 2007 Nov; 28(31):4635-42. PubMed ID: 17664001
[TBL] [Abstract][Full Text] [Related]
4. The effect of rhBMP-2 around endosseous implants with and without membranes in the canine model.
Jones AA; Buser D; Schenk R; Wozney J; Cochran DL
J Periodontol; 2006 Jul; 77(7):1184-93. PubMed ID: 16805681
[TBL] [Abstract][Full Text] [Related]
5. Effect of recombinant human bone morphogenetic protein-2 in dehiscence defects with non-submerged immediate implants: an experimental study in Cynomolgus monkeys.
Hanisch O; Sorensen RG; Kinoshita A; Spiekermann H; Wozney JM; Wikesjö UM
J Periodontol; 2003 May; 74(5):648-57. PubMed ID: 12816297
[TBL] [Abstract][Full Text] [Related]
6. Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects.
Betz OB; Betz VM; Nazarian A; Egermann M; Gerstenfeld LC; Einhorn TA; Vrahas MS; Bouxsein ML; Evans CH
Gene Ther; 2007 Jul; 14(13):1039-44. PubMed ID: 17460719
[TBL] [Abstract][Full Text] [Related]
7. Effect of BMP-2 gene transfer on bone healing in sheep.
Egermann M; Lill CA; Griesbeck K; Evans CH; Robbins PD; Schneider E; Baltzer AW
Gene Ther; 2006 Sep; 13(17):1290-9. PubMed ID: 16642029
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy of bone morphogenetic protein for periodontal tissue engineering.
Jin QM; Anusaksathien O; Webb SA; Rutherford RB; Giannobile WV
J Periodontol; 2003 Feb; 74(2):202-13. PubMed ID: 12666709
[TBL] [Abstract][Full Text] [Related]
9. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.
Virk MS; Conduah A; Park SH; Liu N; Sugiyama O; Cuomo A; Kang C; Lieberman JR
Bone; 2008 May; 42(5):921-31. PubMed ID: 18295562
[TBL] [Abstract][Full Text] [Related]
10. Bone formation as a potential motive force of tooth eruption in the rat molar.
Wise GE; Yao S; Henk WG
Clin Anat; 2007 Aug; 20(6):632-9. PubMed ID: 17415742
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants.
Cochran DL; Schenk R; Buser D; Wozney JM; Jones AA
J Periodontol; 1999 Feb; 70(2):139-50. PubMed ID: 10102551
[TBL] [Abstract][Full Text] [Related]
12. Sclerostin-Neutralizing Antibody Enhances Bone Regeneration Around Oral Implants.
Yu SH; Hao J; Fretwurst T; Liu M; Kostenuik P; Giannobile WV; Jin Q
Tissue Eng Part A; 2018 Nov; 24(21-22):1672-1679. PubMed ID: 29921173
[TBL] [Abstract][Full Text] [Related]
13. Bone regeneration after topical BMP-2-gene delivery in circumferential peri-implant bone defects.
Lutz R; Park J; Felszeghy E; Wiltfang J; Nkenke E; Schlegel KA
Clin Oral Implants Res; 2008 Jun; 19(6):590-9. PubMed ID: 18422983
[TBL] [Abstract][Full Text] [Related]
14. Enhanced bone regeneration around dental implant with bone morphogenetic protein 2 gene and vascular endothelial growth factor protein delivery.
Luo T; Zhang W; Shi B; Cheng X; Zhang Y
Clin Oral Implants Res; 2012 Apr; 23(4):467-73. PubMed ID: 21443590
[TBL] [Abstract][Full Text] [Related]
15. Treatment of peri-implant defects with combination growth factor cement.
Meraw SJ; Reeve CM; Lohse CM; Sioussat TM
J Periodontol; 2000 Jan; 71(1):8-13. PubMed ID: 10695933
[TBL] [Abstract][Full Text] [Related]
16. Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat.
Li JZ; Li H; Sasaki T; Holman D; Beres B; Dumont RJ; Pittman DD; Hankins GR; Helm GA
Gene Ther; 2003 Sep; 10(20):1735-43. PubMed ID: 12939640
[TBL] [Abstract][Full Text] [Related]
17. [Experimental pilot study on surface activation of implants with liposomal vectors].
Thorwarth M; Schlegel KA; Wiltfang J; Rupprecht S; Park JH
Mund Kiefer Gesichtschir; 2004 Jul; 8(4):250-5. PubMed ID: 15293121
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo bone morphogenetic protein-2 gene delivery using bone marrow stem cells in rabbit maxillary sinus augmentation in conjunction with implant placement.
Jhin MJ; Kim KH; Kim SH; Kim YS; Kim ST; Koo KT; Kim TI; Seol YJ; Ku Y; Rhyu IC; Lee YM
J Periodontol; 2013 Jul; 84(7):985-94. PubMed ID: 22897653
[TBL] [Abstract][Full Text] [Related]
19. Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6.
Zachos TA; Shields KM; Bertone AL
J Orthop Res; 2006 Jun; 24(6):1279-91. PubMed ID: 16649180
[TBL] [Abstract][Full Text] [Related]
20. Mineralized nanofiber segments coupled with calcium-binding BMP-2 peptides for alveolar bone regeneration.
Boda SK; Almoshari Y; Wang H; Wang X; Reinhardt RA; Duan B; Wang D; Xie J
Acta Biomater; 2019 Feb; 85():282-293. PubMed ID: 30605770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
